Top-News

La Jolla Pharmaceutical News

Aktie
WKN:  A1XB6B ISIN:  US5034596040 US-Symbol:  LJPC
Keine aktuellen Kursdaten verfügbar
Handeln Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Aktienanzahl *
25,56 Mio.
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 26.07.2022

La Jolla Pharmaceutical News

03.08.22 - PR Newswire
SHAREHOLDER ALERT: Weiss Law Reminds SBTX, LJPC, CNVY, and DRE Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: Weiss Law Reminds SBTX, LJPC, CNVY, and DRE Shareholders About Its Ongoing Investigations PR Newswire
28.07.22 - PR Newswire
SHAREHOLDER ALERT: Weiss Law Reminds SBTX, LJPC, CNVY, and DRE Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: Weiss Law Reminds SBTX, LJPC, CNVY, and DRE Shareholders About Its Ongoing Investigations PR Newswire
27.07.22 - PR Newswire
INVESTIGATION ALERT: Halper Sadeh LLP Investigates ZEN, LJPC, VIVO, PCSB
INVESTIGATION ALERT: Halper Sadeh LLP Investigates ZEN, LJPC, VIVO, PCSB PR Newswire
19.07.22 - PR Newswire
SHAREHOLDER ALERT: Weiss Law Reminds LJPC, CNVY, ACC, and MN Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: Weiss Law Reminds LJPC, CNVY, ACC, and MN Shareholders About Its Ongoing Investigations PR Newswire
18.07.22 - PR Newswire
INVESTIGATION ALERT: Halper Sadeh LLP Investigates LJPC, ZEN, RFP, VHAQ
INVESTIGATION ALERT: Halper Sadeh LLP Investigates LJPC, ZEN, RFP, VHAQ PR Newswire
16.07.22 - PR Newswire
Equity Alert - The M&A Class Action Firm Announces the Investigation of La Jolla Pharmaceutical Co. - LJPC
Equity Alert - The M&A Class Action Firm Announces the Investigation of La Jolla Pharmaceutical Co. - LJPC PR Newswire
12.07.22 - PR Newswire
INVESTIGATION NOTICE: Halper Sadeh LLP Investigates RFP, LJPC, FSI, SYRS
INVESTIGATION NOTICE: Halper Sadeh LLP Investigates RFP, LJPC, FSI, SYRS PR Newswire
11.07.22 - PR Newswire
SHAREHOLDER ALERT: Weiss Law Investigates La Jolla Pharmaceutical Company
SHAREHOLDER ALERT: Weiss Law Investigates La Jolla Pharmaceutical Company PR Newswire
11.07.22 - Der Aktionär
Nächster Übernahme‑Hammer: 70 Prozent Aufschlag!
11.07.22 - PR Newswire
Thinking about buying stock in La Jolla Pharmaceutical, Toughbuilt Industries, Waitr Holdings, Sutro Biopharma, or Magnachip Semiconductor?
Thinking about buying stock in La Jolla Pharmaceutical, Toughbuilt Industries, Waitr Holdings, Sutro Biopharma, or Magnachip Semiconductor? PR Newswire
03.06.21 - PR Newswire
Thinking about buying stock in La Jolla Pharmaceutical, The GEO Group, Abeona Therapeutics, Sellas Life Sciences, or Naked Brand?
Thinking about buying stock in La Jolla Pharmaceutical, The GEO Group, Abeona Therapeutics, Sellas Life Sciences, or Naked Brand? PR Newswire
12.01.21 - PR Newswire
Thinking about buying stock in T2 Biosystems, Zomedica, Aldeyra Therapeutics, La Jolla Pharmaceutical, or US Well Services?
Thinking about buying stock in T2 Biosystems, Zomedica, Aldeyra Therapeutics, La Jolla Pharmaceutical, or US Well Services? PR Newswire
05.06.20 - PR Newswire
Thinking about buying stock in Global Eagle Entertainment, Niu Technologies, TOP Ships, La Jolla Pharmaceutical, or Bank of America?
Thinking about buying stock in Global Eagle Entertainment, Niu Technologies, TOP Ships, La Jolla Pharmaceutical, or Bank of America? PR Newswire
01.05.18 - PR Newswire
CalciMedica Names Two Senior Executives to its Board of Directors
CalciMedica Names Two Senior Executives to its Board of Directors PR Newswire
03.01.18 - The Motley Fool
3 Biotechs bringen 2018 ihre ersten kommerziellen Medikamente auf den Markt
Der Übergang vom Entwickler in der klinischen Phase zum Hersteller in der kommerziellen Phase ist nicht einfach. Das richtige Team zusammenzustellen, kann teuer sein, die ...
17.07.14 - PR Newswire
La Jolla Pharmaceutical Company Analyst Initiation of Coverage: Steer Clear of this Company with a History of Failure by BrokerBank Securities, Inc.
La Jolla Pharmaceutical Company Analyst Initiation of Coverage: Steer Clear of this Company with a History of Failure by BrokerBank Securities, Inc. PR Newswire
30.07.12 - PR Newswire
NYSE, NASDAQ and OTC Companies Webcast Live to Online Investors, August 2nd, at RetailInvestorConferences.com
NYSE, NASDAQ and OTC Companies Webcast Live to Online Investors, August 2nd, at RetailInvestorConferences.com CEOs to take questions in real-time during formal roadshow ...
20.07.12 - PR Newswire
La Jolla Pharmaceutical Company Investor Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com
La Jolla Pharmaceutical Company Investor Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com Company invites individual and institutional ...
10.07.12 - PR Newswire
OTC and NASDAQ-listed Companies Join to Webcast Live on July 12th at RetailInvestorConferences.com
OTC and NASDAQ-​listed Companies Join to Webcast Live on July 12th at RetailInvestorConferences.com CEOs to take questions in real-time during formal roadshow ...
09.07.12 - PR Newswire
Life Sciences Companies Webcast Live to Online Investors, July 12th, at RetailInvestorConferences.com
Life Sciences Companies Webcast Live to Online Investors, July 12th, at RetailInvestorConferences.com CEOs to take questions in real-time during formal roadshow presentations, ...

Newssuche

Videos

06.05.24 +6,89%
Technical Trading: Rohöl Short Chance
Rohöl Short Typ: Turbo Open End WKN: VD4JF9 Hebel: 13 Laufzeit: OpenEnd Einstieg: Market ... Mehr »